DD146050A5 - Verfahren zur herstellung von 9-hydroxyalkylpurinen - Google Patents

Verfahren zur herstellung von 9-hydroxyalkylpurinen Download PDF

Info

Publication number
DD146050A5
DD146050A5 DD79215493A DD21549379A DD146050A5 DD 146050 A5 DD146050 A5 DD 146050A5 DD 79215493 A DD79215493 A DD 79215493A DD 21549379 A DD21549379 A DD 21549379A DD 146050 A5 DD146050 A5 DD 146050A5
Authority
DD
German Democratic Republic
Prior art keywords
purine
substituted
group
amino
chloro
Prior art date
Application number
DD79215493A
Other languages
German (de)
English (en)
Inventor
Alfredo Giner-Sorolla
Original Assignee
Newport Pharmaceuticals
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals, Sloan Kettering Inst Cancer filed Critical Newport Pharmaceuticals
Publication of DD146050A5 publication Critical patent/DD146050A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD79215493A 1978-09-15 1979-09-12 Verfahren zur herstellung von 9-hydroxyalkylpurinen DD146050A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/942,804 US4221910A (en) 1978-09-15 1978-09-15 9-(Hydroxy alkyl)purines

Publications (1)

Publication Number Publication Date
DD146050A5 true DD146050A5 (de) 1981-01-21

Family

ID=25478624

Family Applications (1)

Application Number Title Priority Date Filing Date
DD79215493A DD146050A5 (de) 1978-09-15 1979-09-12 Verfahren zur herstellung von 9-hydroxyalkylpurinen

Country Status (26)

Country Link
US (1) US4221910A (hu)
EP (1) EP0009155B1 (hu)
JP (1) JPS5559188A (hu)
AT (1) ATE1814T1 (hu)
AU (1) AU527881B2 (hu)
CA (1) CA1121818A (hu)
CS (1) CS241023B2 (hu)
DD (1) DD146050A5 (hu)
DE (1) DE2964059D1 (hu)
DK (1) DK145627C (hu)
ES (1) ES484168A1 (hu)
FI (1) FI67847C (hu)
GR (1) GR72523B (hu)
HU (1) HU180892B (hu)
IE (1) IE48826B1 (hu)
IL (1) IL58086A (hu)
IN (1) IN153050B (hu)
MX (1) MX6270E (hu)
NO (1) NO152446C (hu)
NZ (1) NZ191482A (hu)
PH (1) PH15921A (hu)
PL (2) PL124228B1 (hu)
PT (1) PT70179A (hu)
RO (1) RO77559A (hu)
YU (1) YU41885B (hu)
ZA (1) ZA793972B (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4457919A (en) * 1980-03-14 1984-07-03 Newport Pharmaceutical International, Inc. Method of imparting immunomodulating, antiviral or antitumor activity
US4388308A (en) * 1980-06-09 1983-06-14 G.D. Searle & Co. N6 -[(2-Hydroxypropyl)aryl]adenosines
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
JPS59135334A (ja) * 1983-01-24 1984-08-03 Kawasaki Steel Corp デジタル式張力測定装置
IT1213495B (it) * 1986-09-17 1989-12-20 Sigma Tau Ind Farmaceuti Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US5447939A (en) * 1994-07-25 1995-09-05 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
CZ380296A3 (cs) * 1994-07-25 1998-01-14 Alvin J. Glasky Léčivo pro dlouhodobou modifikaci savčí neurální aktivity, léčení neurologických chorob, indukci dlouhodobých změn membránového potenciálu neuronů a jiné účely
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
EP1334104A2 (en) 2000-07-07 2003-08-13 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
NZ546274A (en) * 2003-10-03 2009-12-24 3M Innovative Properties Co Pyrazolopyridines and analags thereof
WO2005074946A1 (en) * 2004-02-10 2005-08-18 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH443312A (fr) * 1963-10-29 1967-09-15 Ajinomoto Kk Procédé de préparation du 1-N-oxyde d'hypoxanthine et du 1-N-oxyde d'inosine substituée ou non, et utilisation des produits obtenus par ce procédé poutilisation des produits obtenus par ce procédé pour la préparation de la 2,6-dichloro-purine et 9-B-D-ribofuranosyl purine substitua ée ou non
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3813394A (en) * 1969-08-18 1974-05-28 Fujisawa Pharmaceutical Co Purine derivatives having hypocholesterolemic activity
JPS504012A (hu) * 1972-12-16 1975-01-16
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4031218A (en) * 1976-04-28 1977-06-21 Mallinckrodt, Inc. 7-(2,3-Dihydroxypropyl-1,3-di-n-propylxanthine and a pharmaceutical composition containing same useful as a bronchial muscle relaxant

Also Published As

Publication number Publication date
IE791752L (en) 1980-03-15
MX6270E (es) 1985-02-27
IL58086A (en) 1982-04-30
PH15921A (en) 1983-04-22
YU41885B (en) 1988-02-29
IE48826B1 (en) 1985-05-29
CA1121818A (en) 1982-04-13
ZA793972B (en) 1980-09-24
EP0009155A1 (en) 1980-04-02
FI67847C (fi) 1985-06-10
RO77559A (ro) 1982-02-01
YU224679A (en) 1984-06-30
IL58086A0 (en) 1979-12-30
ES484168A1 (es) 1980-09-01
EP0009155B1 (en) 1982-11-17
US4221910A (en) 1980-09-09
CS241023B2 (en) 1986-03-13
JPH031310B2 (hu) 1991-01-10
NO152446C (no) 1985-10-02
PL218318A1 (hu) 1980-06-16
PL124177B1 (en) 1982-12-31
GR72523B (hu) 1984-11-16
PL124228B1 (en) 1983-01-31
AU5055679A (en) 1980-03-20
NO792791L (no) 1980-03-18
AU527881B2 (en) 1983-03-31
FI67847B (fi) 1985-02-28
IN153050B (hu) 1984-05-26
JPS5559188A (en) 1980-05-02
NZ191482A (en) 1984-04-27
DE2964059D1 (en) 1982-12-23
DK145627C (da) 1983-06-20
FI792848A (fi) 1980-03-16
CS622779A2 (en) 1985-06-13
PT70179A (en) 1979-10-01
ATE1814T1 (de) 1982-12-15
DK385579A (da) 1980-03-16
HU180892B (en) 1983-05-30
NO152446B (no) 1985-06-24
DK145627B (da) 1983-01-03

Similar Documents

Publication Publication Date Title
DD146050A5 (de) Verfahren zur herstellung von 9-hydroxyalkylpurinen
DD203052A5 (de) Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxy-methyl)-guanin, dessen salzen und bestimmten benzylderivaten desselben
DE3529497A1 (de) N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE69732413T2 (de) Verfahren zur synthese chemischer verbindungen mit pde-iv-hemmender wirkung
DE2165962C2 (de) 4-Hydroxy-6-arylpyrimidine
DE1132784B (de) Konservieren von Pflanzenmaterial mittels Adeninderivaten
DD146049A5 (de) Verfahren zur herstellung von komplexverbindungen von 9-hydroxyalkyl-purinen
EP0130461A2 (de) Neue Imidazole, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2720085C2 (hu)
DE2407115B2 (de) 2,6-Dimethyl-l,4-dihydropyridin-3carbonsäureamino-alkylesterderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2829580C2 (de) 2-Formylchinoxalin-1,4-dioxid-cyanoacetylhydrazon, Verfahren zu seiner Herstellung und Zusammensetzungen mit dieser Verbindung
DE2263100C2 (de) 5,5-Dimethyl-8-(3-methyl-2-octyl)-10-[4-(piperidino)-butyryloxy]-2-(2-propinyl)-1,2,3,4-tetrahydro-5H-[1]-benzopyrano[3,4-d]pyridin, Verfahren zu dessen Herstellung und die Verbindung enthaltende Arzneimittel
DE2708826A1 (de) Substituierte 8-azapurine und verfahren zu ihrer herstellung
DE2758405A1 (de) Arzneimittelzubereitung, enthaltend 1,2,3,3a,4,5-hexahydrocanthinderivate
DE1961595A1 (de) Pyridincarbonylderivate des 7-[Omega(N-Alkylamino)-hydroxyalkyl]-theophyllins und Verfahren zu deren Herstellung
DE2038035A1 (de) 2-Amino-pyrido eckige Klammer auf 2,3-d eckige Klammer zu pyrimidin-4(3H)on-Derivate
EP0180833B1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
DE2460553A1 (de) 2-substituierte adenosin-5'-carboxylate
DE2403786A1 (de) Neue derivate der cumarine
DE2757057A1 (de) Daunomycinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE1283841B (de) Basisch substituierte AEther des AEthanolamins
DE1795384C3 (de) 1 H-2,3-Benzoxazine, Verfahren zu deren Herstellung sowie Arzneimittel
DE2322073A1 (de) Neue aminoderivate von pyridopyridazincarbonsaeureestern und -carbonsaeuren mit ihren salzen
DE1620479C3 (de) Xylitpentanicotinat und dessen Säureadditionssalze
DE1620124C3 (de) 8-Hydroxychinolinderivate

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee